Cargando…
Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial
BACKGROUND: The recurrence rate of periocular nodular basal cell carcinoma (PNBCC) following treatment with imiquimod (IMQ) has not yet been established. Previous studies did not include histological follow-up. The aim of this analysis was to evaluate the efficacy of topical immunotherapy with 5% IM...
Autores principales: | Macedo, Erick Marcet Santiago de, Carneiro, Rachel Camargo, de Lima, Patricia Picciarelli, Silva, Breno Gonçalves, Matayoshi, Suzana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450997/ https://www.ncbi.nlm.nih.gov/pubmed/25885553 http://dx.doi.org/10.1186/s12886-015-0024-0 |
Ejemplares similares
-
Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area
por: Karabulut, Gamze Ozturk, et al.
Publicado: (2017) -
The SINS trial: A randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma
por: Ozolins, Mara, et al.
Publicado: (2010) -
Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998) -
PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
por: Mehta, Vandana, et al.
Publicado: (2008) -
Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
por: Singal, Archana, et al.
Publicado: (2016)